Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

At PSA, Meet The New Deal-Makers (Part 1)

Sep 30 2010

• By Wendy Diller

Related Content

AstraZeneca Pares R&D Areas By 25 Percent, But Will Continue Licensing

Mar 08 2010

Big Pharmas Come Together On TB, But Effort To Accelerate Development May Hit Speedbump From Lack Of Biomarkers

Mar 29 2010

AstraZeneca Names A New Head Of Business Development & Licensing

Mar 30 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window